VPS33A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.394000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.135000E-01
Normal-vs-Stage2
9.187700E-02
Normal-vs-Stage3
4.560500E-02
Normal-vs-Stage4
3.861400E-01
Stage1-vs-Stage2
1.600360E-01
Stage1-vs-Stage3
4.477800E-02
Stage1-vs-Stage4
6.691200E-01
Stage2-vs-Stage3
8.403900E-02
Stage2-vs-Stage4
5.352200E-01
Stage3-vs-Stage4
7.190300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.833400E-01
Normal-vs-AfricanAmerican
1.920020E-01
Normal-vs-Asian
2.836400E-02
Caucasian-vs-AfricanAmerican
7.452400E-01
Caucasian-vs-Asian
8.818200E-02
AfricanAmerican-vs-Asian
2.745200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.376200E-01
Normal-vs-Female
2.581000E-01
Male-vs-Female
7.063800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.690200E-01
Normal-vs-Age(41-60Yrs)
3.631200E-01
Normal-vs-Age(61-80Yrs)
1.885020E-01
Normal-vs-Age(81-100Yrs)
3.182800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.871200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.858000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.194200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.021800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.833400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.095700E-02
Normal-vs-Daily Drinker
7.261900E-02
Normal-vs-Weekly Drinker
1.354770E-01
Normal-vs-Occasional Drinker
7.024400E-01
Normal-vs-Social Drinker
4.100200E-01
Non Drinker-vs-Daily Drinker
4.003400E-01
Non Drinker-vs-Weekly Drinker
6.672200E-01
Non Drinker-vs-Occasional Drinker
5.924200E-02
Non Drinker-vs-Social Drinker
1.286390E-01
Daily Drinker-vs-Weekly Drinker
8.130800E-01
Daily Drinker-vs-Occasional Drinker
1.559160E-01
Daily Drinker-vs-Social Drinker
3.801600E-01
Weekly Drinker-vs-Occasional Drinker
1.769950E-01
Weekly Drinker-vs-Social Drinker
3.901400E-01
Occasional Drinker-vs-Social Drinker
5.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.912400E-01
Normal-vs-Grade 2
7.022400E-01
Normal-vs-Grade 3
6.681400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.019000E-01
Grade 1-vs-Grade 3
3.386000E-01
Grade 1-vs-Grade 4
3.912400E-01
Grade 2-vs-Grade 3
4.629600E-01
Grade 2-vs-Grade 4
7.022400E-01
Grade 3-vs-Grade 4
6.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.443970E-01
Normal-vs-NonDiabetic
2.453800E-01
Diabetic-vs-NonDiabetic
5.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.128170E-01
Normal-vs-NoPancreatitis
2.569800E-01
Pancreatitis-vs-NoPancreatitis
4.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.075400E-01
Normal-vs-N1
9.088200E-02
N0-vs-N1
1.699160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.641800E-02
Normal-vs-TP53-NonMutant
6.550400E-01
TP53-Mutant-vs-TP53-NonMutant
1.095950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
